Chester County News and Community Website
EXTON, PA — Television chef and Exton resident Eric Theiss underwent a minimally invasive outpatient procedure in December 2025 after nearly three decades of chronic lower back pain, turning to …
Exton TV Chef Turns to New Approach After Decades of Back Pain Read More
MALVERN, PA — MAXONA Pharmaceuticals has received U.S. Food and Drug Administration clearance to begin a Phase 2 clinical trial of its investigational non-opioid pain therapy, advancing the company’s effort …
FDA Clears MAXONA Pain Drug for Phase 2 Trial Read More
PHILADELPHIA, PA — Dr. Asif Ilyas, president of the Rothman Institute Foundation for Opioid Research & Education, Professor of Orthopaedic Surgery at Thomas Jefferson University and Associate Dean of Clinical …
Dr. Asif Ilyas Named a 2026 Castle Connolly Top Doctor Read More MALVERN, PA — MAXONA Pharmaceuticals has taken a key step toward advancing its flagship pain therapy, filing an Investigational New Drug (IND) application with the U.S. Food and Drug Administration …
MAXONA Pharmaceuticals Submits FDA Application for Non-Opioid Pain Treatment Read More
PHILADELPHIA, PA — This June, as we observe Post-Traumatic Stress Disorder (PTSD) Awareness Month, a convergence of anniversaries provides a solemn opportunity for reflection. In 2025, we will commemorate the …
The Unseen Scars of 250 Years of Service: PTSD and the Opioid Crisis Read More
PHILADELPHIA, PA — Dr. Asif Ilyas, a distinguished surgeon with Rothman Orthopaedics in Philadelphia, has been named to the 2025 Orthopedic Surgery Research All Stars, placing him among the top …
Dr. Asif Ilyas Named to Orthopedic Surgery Research All Stars Top 3% Nationwide by Avant-Garde Health Read More
PHILADELPHIA, PA — The results of a new study suggest patients with chronic pain are turning to medical cannabis to find relief and are also breaking free from traditional painkillers …
Medical Cannabis Reduces Pain and Opioid Pill Use, Preserves Cognition, Study Reveals Read More
PHILADELPHIA, PA — A recent study conducted across nine Iowa hospitals has shown promising results in reducing postoperative opioid prescriptions by implementing Enhanced Recovery After Surgery (ERAS) pathways.
Enhanced Recovery Pathways Slash Opioid Prescriptions Read More
BERWYN, PA — Virpax Pharmaceuticals, Inc. (Nasdaq: VRPX) has commended Nanomerics for the successful completion of a human study utilizing its proprietary Molecular Envelope Technology (MET). The Phase I SUNLIGHT trial …
Virpax Pharmaceuticals Applauds Successful Trial of Molecular Envelope Technology Read More MALVERN, PA — MAXONA Pharmaceuticals has officially emerged from stealth mode, announcing the successful completion of its U.S. Phase 1 clinical trials for MAX-001, a groundbreaking non-opioid, non-NSAID oral therapy designed …
MAXONA Pharmaceuticals Completes Phase 1 Trials for Breakthrough Pain Therapy Read More